Table 2.
Complications experienced by patients over the course of COVID-19.
| Complications — no. (%) | N = 70 |
|---|---|
| Pulmonary complications | 28 (40) |
| Pneumothorax | 9 (12.86) |
| Pleural effusion | 8 (11.43) |
| Bronchiolitis | 12 (17.14) |
| Cardiac complications | 17 (24.29) |
| Heart failure | 6 (8.57) |
| Cardiac arrest | 8 (11.43) |
| Severe arrhythmia | 5 (7.14) |
| Ischemia | 2 (2.86) |
| Infectious complications | 46 (65.71) |
| Fungal infection | 9 (12.86) |
| Bacterial infection | 42 (60.0) |
| Pneumonia | 21 (30.0) |
| Bacteremia | 15 (21.43) |
| Sepsis | 15 (21.43) |
| Endocarditis | 1 (1.43) |
| Neurological complications | 4 (5.71) |
| Convulsions | 1 (1.43) |
| Cerebrovascular accident | 1 (1.43) |
| Hematological complications | 22 (31.43) |
| Disseminated intravascular coagulation | 5 (7.14) |
| Anemia with transfusion | 13 (18.57) |
| Renal complications | 29 (41.43) |
| Acute kidney failure | 23 (32.86) |
| Digestive complications | 15 (21.43) |
| Gastrointestinal hemorrhage | 5 (7.14) |
| Pancreatitis | 1 (1.43) |
| Hepatic failure | 5 (7.14) |
| Rhabdomyolysis | 2 (2.86) |
| Acute respiratory distress | 51 (72.86) |